Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
North Carolina Voter Guide 2024: Who's running, how, where, when to vote in NC election
Recommended
Help North Carolina rebuild: WRAL's Hurricane Helene recovery fund raises $900K+
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rapport Therapeutics, Inc. - Common Stock
(NQ:
RAPP
)
25.95
-2.10 (-7.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
115,523
Open
28.23
Bid (Size)
20.40 (5)
Ask (Size)
41.95 (2)
Prev. Close
28.05
Today's Range
25.89 - 29.22
52wk Range
16.55 - 29.74
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
October 18, 2024
Via
Benzinga
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
September 05, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
+24.76%
+24.76%
1 Month
+24.52%
+24.52%
3 Month
+28.98%
+28.98%
6 Month
+24.76%
+24.76%
1 Year
+24.76%
+24.76%
More News
Read More
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
August 29, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
The 3 Best Healthcare Stocks to Buy in August 2024
August 12, 2024
Via
InvestorPlace
RAPP Stock Earnings: Rapport Therapeutics Misses EPS for Q2 2024
August 10, 2024
Via
InvestorPlace
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
August 08, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns
August 06, 2024
Via
InvestorPlace
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
July 29, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
June 12, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Why Contango Ore Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 11, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.